These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 17126291

  • 1. A transgenic rat with the human ATTR V30M: a novel tool for analyses of ATTR metabolisms.
    Ueda M, Ando Y, Hakamata Y, Nakamura M, Yamashita T, Obayashi K, Himeno S, Inoue S, Sato Y, Kaneko T, Takamune N, Misumi S, Shoji S, Uchino M, Kobayashi E.
    Biochem Biophys Res Commun; 2007 Jan 12; 352(2):299-304. PubMed ID: 17126291
    [Abstract] [Full Text] [Related]

  • 2. Effect of albumin on transthyretin and amyloidogenic transthyretin Val30Met disposition and tissue deposition in familial amyloidotic polyneuropathy.
    Taguchi K, Jono H, Kugimiya-Taguchi T, Nagao S, Su Y, Yamasaki K, Mizuguchi M, Maruyama T, Ando Y, Otagiri M.
    Life Sci; 2013 Dec 18; 93(25-26):1017-22. PubMed ID: 24211615
    [Abstract] [Full Text] [Related]

  • 3. Modeling familial amyloidotic polyneuropathy (Transthyretin V30M) in Drosophila melanogaster.
    Berg I, Thor S, Hammarström P.
    Neurodegener Dis; 2009 Dec 18; 6(3):127-38. PubMed ID: 19372706
    [Abstract] [Full Text] [Related]

  • 4. A different amyloid formation mechanism: de novo oculoleptomeningeal amyloid deposits after liver transplantation.
    Ando Y, Terazaki H, Nakamura M, Ando E, Haraoka K, Yamashita T, Ueda M, Okabe H, Sasaki Y, Tanihara H, Uchino M, Inomata Y.
    Transplantation; 2004 Feb 15; 77(3):345-9. PubMed ID: 14966406
    [Abstract] [Full Text] [Related]

  • 5. Antibody therapy for familial amyloidotic polyneuropathy.
    Su Y, Jono H, Torikai M, Hosoi A, Soejima K, Guo J, Tasaki M, Misumi Y, Ueda M, Shinriki S, Shono M, Obayashi K, Nakashima T, Sugawara K, Ando Y.
    Amyloid; 2012 Jun 15; 19 Suppl 1():45-6. PubMed ID: 22506915
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Potential use of glucuronylglucosyl-β-cyclodextrin as a novel therapeutic tool for familial amyloidotic polyneuropathy.
    Jono H, Anno T, Motoyama K, Misumi Y, Tasaki M, Oshima T, Mori Y, Mizuguchi M, Ueda M, Shinriki S, Shono M, Obayashi K, Arima H, Ando Y.
    Amyloid; 2012 Jun 15; 19 Suppl 1():50-2. PubMed ID: 22620966
    [Abstract] [Full Text] [Related]

  • 8. CNS involvement in V30M transthyretin amyloidosis: clinical, neuropathological and biochemical findings.
    Maia LF, Magalhães R, Freitas J, Taipa R, Pires MM, Osório H, Dias D, Pessegueiro H, Correia M, Coelho T.
    J Neurol Neurosurg Psychiatry; 2015 Feb 15; 86(2):159-67. PubMed ID: 25091367
    [Abstract] [Full Text] [Related]

  • 9. Deposition of transthyretin amyloid is not accelerated by the same amyloid in vivo.
    Wei L, Kawano H, Fu X, Cui D, Ito S, Yamamura K, Ishihara T, Tokuda T, Higuchi K, Maeda S.
    Amyloid; 2004 Jun 15; 11(2):113-20. PubMed ID: 15478467
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Doxycycline disrupts transthyretin amyloid: evidence from studies in a FAP transgenic mice model.
    Cardoso I, Saraiva MJ.
    FASEB J; 2006 Feb 15; 20(2):234-9. PubMed ID: 16449795
    [Abstract] [Full Text] [Related]

  • 13. SELDI-TOF mass spectrometry evaluation of variant transthyretins for diagnosis and pathogenesis of familial amyloidotic polyneuropathy.
    Ueda M, Misumi Y, Mizuguchi M, Nakamura M, Yamashita T, Sekijima Y, Ota K, Shinriki S, Jono H, Ikeda S, Suhr OB, Ando Y.
    Clin Chem; 2009 Jun 15; 55(6):1223-7. PubMed ID: 19372189
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Activation of the heat shock response in familial amyloidotic polyneuropathy.
    Santos SD, Magalhães J, Saraiva MJ.
    J Neuropathol Exp Neurol; 2008 May 15; 67(5):449-55. PubMed ID: 18431252
    [Abstract] [Full Text] [Related]

  • 17. Liver transplantation and new therapeutic approaches for familial amyloidotic polyneuropathy (FAP).
    Ando Y.
    Med Mol Morphol; 2005 Sep 15; 38(3):142-54. PubMed ID: 16170462
    [Abstract] [Full Text] [Related]

  • 18. Multi-elemental analysis of serum and amyloid fibrils in familial amyloid polyneuropathy patients.
    Susuki S, Ando Y, Sato T, Nishiyama M, Miyata M, Suico MA, Shuto T, Kai H.
    Amyloid; 2008 Jun 15; 15(2):108-16. PubMed ID: 18484337
    [Abstract] [Full Text] [Related]

  • 19. Presence of N-glycosylated transthyretin in plasma of V30M carriers in familial amyloidotic polyneuropathy: an escape from ERAD.
    Teixeira AC, Saraiva MJ.
    J Cell Mol Med; 2013 Mar 15; 17(3):429-35. PubMed ID: 23387326
    [Abstract] [Full Text] [Related]

  • 20. Liver transplantation in transthyretin amyloidosis: issues and challenges.
    Carvalho A, Rocha A, Lobato L.
    Liver Transpl; 2015 Mar 15; 21(3):282-92. PubMed ID: 25482846
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.